Biotech

All Articles

Cullinan, after $25M deal, hands back bispecific to Harbour

.Cullinan Therapy was thrilled enough with Port BioMed's bispecific immune activator that it handed ...

A deeper take a look at Tough Biotech's Fierce 15

.In this week's incident of "The Leading Pipe," our company are actually diving into Fierce Biotech'...

Lilly faces stage 2 failing of tau-targeting med

.The confetti is actually still flying from Eli Lilly's celebration commemorating the commendation o...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable management hirings, firings and a...

Lykos will definitely talk to FDA to reconsider its own choice adhering to turndown of MDMA therapy for post-traumatic stress disorder

.Observing an unsatisfactory revealing for Lykos Rehabs' MDMA prospect for post-traumatic stress dis...

AN 2 fifty percents headcount, stops stage 3 test after data dissatisfy

.AN2 Rehabs is actually reassessing its own company in feedback to uninspired midphase information, ...

Merck pays $700M for bispecific, snooping autoimmune opening and also chance to test Amgen in cancer cells

.Merck &amp Co. is actually paying $700 thousand beforehand to test Amgen in a blood cancer cells ma...

Gilead pays out J&ampJ $320M to leave licensing bargain for seladelpar

.With Gilead Sciences about to an FDA decision for its liver ailment medicine seladelpar, the provid...

' All hands on deck' at Lilly as peers target being overweight market

.CEO David Ricks may see the companies putting together camping tents at basecamp behind Eli Lilly i...

Entero giving up staff, vacating workplace and also pausing R&ampD

.Mattress Liquidators has switched Entero Therapeutics white as a slab. The lender bought Entero to ...